A phase I study of lenalidomide in combination with fludarabine and rituximab in previously untreated CLL/SLL

被引：49

作者：

Brown, J. R. ^{[1
,2
]}

Abramson, J. ^{[2
,3
]}

Hochberg, E. ^{[2
,3
]}

Mikler, E. ^{[1
]}

Dalton, V. ^{[1
]}

Werner, L. ^{[4
]}

Reynolds, H. ^{[1
]}

Thompson, C. ^{[1
]}

McDonough, S. M. ^{[1
]}

Kuang, Y. ^{[5
]}

Ritz, J. ^{[1
,2
]}

Neuberg, D. ^{[4
]}

Freedman, A. S. ^{[1
,2
]}

机构：

[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA

[3] Massachusetts Gen Hosp, Dept Med, Div Oncol, Boston, MA 02114 USA

[4] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA

[5] Dana Farber Canc Inst, Ctr Clin & Translat Res, Boston, MA 02115 USA

来源：

LEUKEMIA | 2010年 / 24卷 / 11期

关键词：

D O I：

10.1038/leu.2010.199

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1972 / 1975

页数：5

共 8 条

[1] Higher doses of lenalidomide are associated with unacceptable toxicity including life-threatening tumor flare in patients with chronic lymphocytic leukemia [J].

Andritsos, Leslie A. ;

Johnson, Amy J. ;

Lozanski, Gerard ;

Blum, William ;

Kefauver, Cheryl ;

Awan, Farrukh ;

Smith, Lisa L. ;

Lapalombella, Rosa ;

May, Sarah E. ;

Raymond, Chelsey A. ;

Wang, Da-Sheng ;

Knight, Robert D. ;

Ruppert, Amy S. ;

Lehman, Amy ;

Jarjoura, David ;

Chen, Ching-Shih ;

Byrd, John C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2519-2525

[2] Lenalidomide-induced upregulation of CD80 on tumor cells correlates with T-cell activation, the rapid onset of a cytokine release syndrome and leukemic cell clearance in chronic lymphocytic leukemia [J].

Aue, Georg ;

Njuguna, Ndegwa ;

Tian, Xin ;

Soto, Susan ;

Hughes, Thomas ;

Vire, Berengere ;

Keyvanfar, Keyvan ;

Gibellini, Federica ;

Valdez, Janet ;

Boss, Carol ;

Samsel, Leigh ;

McCoy, J. Philip, Jr. ;

Wilson, Wyndham H. ;

Pittaluga, Stefania ;

Wiestner, Adrian .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09) :1266-1273

[3] Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: Results of a phase II study [J].

Chanan-Khan, Asher ;

Miller, Kena C. ;

Musial, Laurie ;

Lawrence, David ;

Padmanabhan, Swaminathan ;

Takeshita, Kenichi ;

Porter, Carl W. ;

Goodrich, David W. ;

Bernstein, Zale P. ;

Wallace, Paul ;

Spaner, David ;

Mohr, Alice ;

Byrne, Catriona ;

Hernandez-Ilizaliturri, Francisco ;

Chrystal, Cynthia ;

Starostik, Petr ;

Czuczman, Myron S. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5343-5349

[4] The REVLIRIT CLL5 AGMT Study - a Phase I/II Trial Combining Fludarabine/Rituximab with Escalating Doses of Lenalidomide Followed by Rituximab/Lenalidomide in Untreated Chronic Lymphocytic Leukemia (CLL): Results of a Planned Interim Analysis [J].

Egle, Alexander ;

Steurer, Michael ;

Melchardt, Thomas ;

Stoll, Marion ;

Greil, Richard .

BLOOD, 2009, 114 (22) :1341-1342

[5] Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia [J].

Ferrajoli, Alessandra ;

Lee, Bang-Ning ;

Schlette, Ellen J. ;

O'Brien, Susan M. ;

Gao, Hui ;

Wen, Sijin ;

Wierda, William G. ;

Estrov, Zeev ;

Faderl, Stefan ;

Cohen, Evan N. ;

Li, Changping ;

Reuben, James M. ;

Keating, Michael J. .

BLOOD, 2008, 111 (11) :5291-5297

[6] Combination Therapy with Lenalidomide and Rituximab in Patients with Relapsed Chronic Lymphocytic Leukemia (CLL) [J].

Ferrajoli, Alessandra ;

Badoux, Xavier C. ;

O'Brien, Susan ;

Wierda, William G. ;

Faderl, Stefan ;

Estrov, Zeev ;

Pasia, Manolo ;

Lee, Bang-Ning ;

Reuben, James M. ;

Kantarjian, Hagop ;

Keating, Michael .

BLOOD, 2009, 114 (22) :89-90

[7] Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway [J].

Lapalombella, Rosa ;

Andritsos, Leslie ;

Liu, Qing ;

May, Sarah E. ;

Browning, Rebekah ;

Pham, Lan V. ;

Blum, Kristie A. ;

Blum, William ;

Ramanunni, Asha ;

Raymond, Chelsey A. ;

Smith, Lisa L. ;

Lehman, Amy ;

Mo, Xiaokui ;

Jarjoura, David ;

Chen, Ching-Shih ;

Ford, Richard, Jr. ;

Rader, Christoph ;

Muthusamy, Natarajan ;

Johnson, Amy J. ;

Byrd, John C. .

BLOOD, 2010, 115 (13) :2619-2629

[8] Tumor lysis syndrome/tumor flare reaction in lenalidomide-treated chronic lymphocytic leukemia [J].

Moutouh-de Parseval, Laure A. ;

Weiss, Lilia ;

DeLap, Robert J. ;

Knight, Robert D. ;

Zeldis, Jerome B. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (31) :5047-5047

← 1 →